Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1190-1197

  Shan, Changliang ^a   Zhang, Shuai ^a   Cui, Wenjing ^a   You, Xiaona ^a   Kong, Guangyao ^a   Du, Yumei ^a   Qiu, Liyan ^a   Ye, Lihong ^b   Zhang, Xiaodong ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HEPATITIS B VIRUS X PROTEIN; LET 7I PROTEIN; MESSENGER RNA; PEPTIDES AND PROTEINS; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL SURFACE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION;

EID: 79961184589     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr106     Document Type: Article

References (39)

1. Kim,C.M. et al. (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature, 351, 317-320.
2. Chang,J.J. et al. (2007) Immunopathogenesis of hepatitis B virus infection. Immunol. Cell Biol., 85, 16-23.
3. Guidotti,L.G. et al. (2006) Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol., 1, 23-61.
4. Gurtsevitch,V.E. (2008) Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochemistry (Mosc.), 73, 504-513.
5. Tang,H. et al. (2006) Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci., 97, 977-983.
6. Kanda,T. et al. (2006) State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus X. Cancer Lett., 234, 143-148.
7. Ng,R.K. et al. (2004) cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem. Biophys. Res. Commun., 322, 827-835.
8. Zhang,X. et al. (2006) Effects of hepatitis B virus X protein on the development of liver cancer. J. Lab. Clin. Med., 147, 58-66.
9. Maguire,H.F. et al. (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science, 252, 842-844.
10. Williams,J.S. et al. (1995) The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc. Natl. Acad. Sci. USA, 92, 3819-3823.
11. Kirschfink,M. (2001) Targeting complement in therapy. Immunol. Rev., 180, 177-189.
12. Bjorge,L. et al. (2005) Ascitic complement system in ovarian cancer. Br. J. Cancer, 92, 895-905.
13. Gorter,A. et al. (1999) Immune evasion of tumor cells using membranebound complement regulatory proteins. Immunol. Today, 20, 576-582.
14. Halme,J. et al. (2009) Primary human hepatocytes are protected against complement by multiple regulators. Mol. Immunol., 46, 2284-2289.
15. Iborra,A. et al. (2003) Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells. Cell Immunol., 223, 46-51.
16. Kinugasa,N. et al. (1999) Expression of membrane cofactor protein (MCP, CD46) in human liver diseases. Br. J. Cancer, 80, 1820-1825.
17. Murray,K.P. et al. (2000) Expression of complement regulatory proteins- CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. Gynecol. Oncol., 76, 176-182.
18. Spiller,O.B. et al. (2000) Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack. Clin. Exp. Immunol., 121, 234-241.
19. Lin,F. et al. (2004) Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis. J. Immunol., 172, 2636-2642.
20. Xu,L. et al. (2006) Cooperation between human DAF and CD59 in protecting cells from human complement-mediated lysis. J. Biochem. Mol. Biol., 39, 743-748.
21. Ajona,D. et al. (2007) Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth. J. Immunol., 178, 5991-5998.
22. Zhu,X. et al. (2008) Activity after site-directed mutagenesis of CD59 on complement-mediated cytolysis. Cell Mol. Immunol., 5, 141-146.
23. Bueno,M.J. et al. (2008) Control of cell proliferation pathways by micro-RNAs. Cell Cycle, 7, 3143-3148.
24. Chen,Y. et al. (2008) Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood, 111, 1217-1226.
25. Wang,Y. et al. (2010) Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J. Hepatol., 53, 57-66.
26. Sells,M.A. et al. (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA, 84, 1005-1009.
27. Wang,Q. et al. (2010) A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. Neoplasia, 12, 103-115.
28. Ye,L. et al. (2008) Progressive changes in hepatoma cells stably transfected with hepatitis B virus X gene. Intervirology, 51, 50-58.
29. Zhang,X. et al. (2005) Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J. Med. Virol., 77, 374-381.
30. Zhang,H. et al. (2008) Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation. Acta Pharmacol. Sin., 29, 473-480.
31. Schmittgen,T.D. et al. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
32. Shan,C. et al. (2010) Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2. Cell Res., 20, 563-575.
33. Tone,M. et al. (1999) High level transcription of the complement regulatory protein CD59 requires an enhancer located in intron 1. J. Biol. Chem., 274, 710-716.
34. Macor,P. et al. (2006) Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma. Cancer Res., 66, 3876-3883.
35. Uliasz,T.F. et al. (2000) A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture. J. Neurosci. Methods, 100, 157-163.
36. Ziller,F. et al. (2005) Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59. Eur. J. Immunol., 35, 2175-2183.
37. Fang,H. et al. (2005) Identification of a functional CRE in the promoter of Fukuyama congenital muscular dystrophy gene fukutin. Brain. Res. Mol. Brain. Res., 136, 1-11.
38. Chen,S. et al. (2000) CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma. Cancer Res., 60, 3013-3018.
39. Lara-Pezzi,E. et al. (2003) Role of the hepatitis B virus X protein (HBx) in immune response and tumoral progression. Gastroenterol. Hepatol., 26, 552-561.